Molecular characterization by the 21-gene breast cancer (BC) Recurrence Score (RS) test of BRCA1/2 mutation carriers (mBRCA1/2) versus the general BC patient (pt) population

被引：1

作者：

Yerushalmi, R. ^{[1
]}

Pomerantz, A. ^{[1
]}

Lewin, R. ^{[2
]}

Paluch-Shimon, S. ^{[3
]}

Soussan-Gutman, L. ^{[4
]}

Baehner, F. L. ^{[5
]}

Voet, H. ^{[6
]}

Bareket-Samish, A. ^{[7
]}

Kedar, I. ^{[8
]}

Kaduri, L. ^{[9
]}

机构：

[1] Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel

[2] Chaim Sheba Med Ctr, Dept Oncol, Ramat Gan, Israel

[3] Hadassah Univ Hosp Ein Kerem, Sharett Inst Oncol, Jerusalem, Israel

[4] Rhenium Oncotest, Oncotest, Modiin, Israel

[5] Exact Sci Corp, Dept Med, Madison, WI USA

[6] Hebrew Univ Jerusalem, Environm Econ & Management, Rehovot, Israel

[7] BioInsight Ltd, Res, Binyamina, Israel

[8] Raphael Recanati Genet Inst, Rabin Med Ctr, Petah Tiqwa, Israel

[9] Hadassah Hebrew Univ, Ctr Canc Genet, Med Ctr, Jerusalem, Israel

来源：

关键词：

D O I：

10.1016/j.annonc.2022.07.187

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

152P

引用

页码：S609 / S609

页数：1